{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidu662mllukp5cg64dwlubwr76wd7polgh3sfzw7gb57e2aree4ty",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjfrafx5rpx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreied42kyjzmu7i47sjo74bilgufbsl5oz5c7lnaxxn4t26remdfhri"
    },
    "mimeType": "image/jpeg",
    "size": 103259
  },
  "path": "/2026/04/13/biotech-news-gsk-advacing-ovarian-cancer-drug-mo-rez/?utm_campaign=rss",
  "publishedAt": "2026-04-13T13:25:46.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "Cancer",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "Revolution Medicines 'unprecedented' cancer trial data, Allogene's off-the-shelf CAR-T, and other biotech news",
  "title": "STAT+: GSK advancing ovarian cancer drug mo-rez",
  "updatedAt": "2026-04-13T13:25:50.000Z"
}